NO973459D0 - Vismut-forbindelser - Google Patents

Vismut-forbindelser

Info

Publication number
NO973459D0
NO973459D0 NO973459A NO973459A NO973459D0 NO 973459 D0 NO973459 D0 NO 973459D0 NO 973459 A NO973459 A NO 973459A NO 973459 A NO973459 A NO 973459A NO 973459 D0 NO973459 D0 NO 973459D0
Authority
NO
Norway
Prior art keywords
bismuth compounds
bismuth
compounds
Prior art date
Application number
NO973459A
Other languages
English (en)
Other versions
NO973459L (no
Inventor
Jo Klaveness
Arne Berg
Torsten Almen
Klaes Golman
Michael Droege
Shi-Bao Yu
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9501560.8A external-priority patent/GB9501560D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO973459D0 publication Critical patent/NO973459D0/no
Publication of NO973459L publication Critical patent/NO973459L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO973459A 1995-01-26 1997-07-25 Vismut-forbindelser NO973459L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9501560.8A GB9501560D0 (en) 1995-01-26 1995-01-26 Contrast agents
US08/486,225 US5817289A (en) 1995-01-26 1995-06-07 Non-cluster type bismuth compounds
PCT/GB1996/000183 WO1996022994A1 (en) 1995-01-26 1996-01-26 Bismuth compounds

Publications (2)

Publication Number Publication Date
NO973459D0 true NO973459D0 (no) 1997-07-25
NO973459L NO973459L (no) 1997-09-25

Family

ID=26306382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973459A NO973459L (no) 1995-01-26 1997-07-25 Vismut-forbindelser

Country Status (11)

Country Link
US (1) US6117412A (no)
EP (1) EP0805815B1 (no)
JP (1) JPH10512877A (no)
CN (1) CN1177357A (no)
AU (1) AU4493796A (no)
CA (1) CA2211873A1 (no)
DE (1) DE69620582T2 (no)
FI (1) FI973117A (no)
HU (1) HUP9900428A2 (no)
NO (1) NO973459L (no)
WO (1) WO1996022994A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19635419C1 (de) * 1996-08-23 1998-08-20 Schering Ag Wismutdendrimere und ihre Verwendung als Röntgenkontrastmittel
KR100721365B1 (ko) * 2003-04-08 2007-05-23 토소가부시키가이샤 신규 비스무트 화합물, 그 제조방법 및 막의 제조방법
WO2005014567A1 (en) * 2003-08-12 2005-02-17 Biocon Limited Mycophenolic acid bismuth salt
US7632924B2 (en) 2004-06-18 2009-12-15 Ambrx, Inc. Antigen-binding polypeptides and their uses
CN1986554B (zh) * 2005-12-20 2010-08-11 上海化学试剂研究所 三(4-乙氧基苯基)铋的制备方法
EP2192922A4 (en) 2007-09-17 2010-09-29 Univ California INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGING PROSTATE <I> IN SITU CANCER CELLS </ I>
US20110064674A1 (en) * 2008-05-21 2011-03-17 Carnegie Mellon University Luminescent multimodal nanoparticle probe system and method of manufacture thereof
EP2684048B1 (en) 2011-03-11 2018-10-03 Board of Regents of the University of Nebraska Biomarker for coronary artery disease
CN103771456A (zh) * 2012-10-26 2014-05-07 吴学文 一种铁氰化铋化合物及其纳米ct造影剂的制备方法
US10377775B2 (en) 2014-12-04 2019-08-13 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end
JP6460937B2 (ja) * 2014-12-04 2019-01-30 信越化学工業株式会社 末端にアミノ基を有するポリアルキレングリコール誘導体の製造方法
US9708350B2 (en) 2014-12-04 2017-07-18 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator
US10946106B2 (en) 2015-11-30 2021-03-16 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
WO2019177084A1 (ja) 2018-03-16 2019-09-19 株式会社トクヤマ ビスマス化合物、硬化性組成物、および硬化体
JPWO2022014591A1 (no) 2020-07-17 2022-01-20
IL300528A (en) 2020-08-07 2023-04-01 Fortis Therapeutics Inc Immune conjugates targeting cd46 and methods of using them

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003685A (en) * 1961-06-29 1965-09-08 American Cyanamid Co Improvements in or relating to germicidal finishes
US3239411A (en) * 1962-06-14 1966-03-08 M & T Chemicals Inc Organo bismuth biocide
US3247050A (en) * 1962-10-11 1966-04-19 M & T Chemicals Inc Organo bismuth biocide
US3466366A (en) * 1963-05-15 1969-09-09 M & T Chemicals Inc Method of controlling bacteria with an organobismuth ethylenic carboxylate and polymer thereof
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
US3753990A (en) * 1972-01-17 1973-08-21 Procter & Gamble Phenylbismuth bis(2-pyridinethiol 1-oxide)
BE809388A (en) * 1974-01-04 1974-05-02 Bismuthyl prostanoate derivs for ulcer control - in digestive system and prepd from prostanoic acid with bismuth oxide, hydroxide or salt
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
JPS63225381A (ja) * 1986-08-29 1988-09-20 Nippon Zeon Co Ltd 肝疾患治療剤
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
DE3869251D1 (de) * 1987-07-16 1992-04-23 Nycomed As Aminopolycarbonsaeure und ihre derivate.
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
CH679582A5 (no) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
DE59003811D1 (de) * 1989-09-07 1994-01-20 Thomas Gergely Magensäure bindende, pharmazeutische zubereitung.
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
WO1992017215A1 (en) * 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
ATE135227T1 (de) * 1990-07-20 1996-03-15 Slagel David Produkte und verfahren zur behandlung des verdauungskanals
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2052698A1 (en) * 1990-10-11 1992-04-12 Roger G. Berlin Treatment of peptic ulcer
ATE203416T1 (de) * 1991-08-05 2001-08-15 Mallinckrodt Inc Schwermetallcluster zur verwendung als abbildungsmittel
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
JP3668983B2 (ja) * 1993-08-23 2005-07-06 日産化学工業株式会社 トリス（置換フェニル）ビスマス誘導体
US5482669A (en) * 1994-05-23 1996-01-09 General Motors Corporation Pulsating gas-assisted injection molding method and apparatus
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
JPH10509734A (ja) * 1994-11-30 1998-09-22 シェリング アクチェンゲゼルシャフト 肝臓及び胆嚢用ｘ線診断薬剤としての金属錯体の使用
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents

Also Published As

Publication number Publication date
WO1996022994A1 (en) 1996-08-01
CN1177357A (zh) 1998-03-25
FI973117A (fi) 1997-09-25
DE69620582D1 (de) 2002-05-16
US6117412A (en) 2000-09-12
FI973117A0 (fi) 1997-07-25
DE69620582T2 (de) 2002-11-07
NO973459L (no) 1997-09-25
EP0805815B1 (en) 2002-04-10
EP0805815A1 (en) 1997-11-12
MX9705609A (es) 1997-10-31
HUP9900428A2 (hu) 1999-06-28
AU4493796A (en) 1996-08-14
CA2211873A1 (en) 1996-08-01
JPH10512877A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
ID16345A (id) Senyawa-senyawa heterosiklik
DK0777671T3 (da) Spiro-azabicykliske forbindelser
DK1114817T3 (da) Substituerede benzylaminopiperidinforbindelser
FI972970A (fi) Uusia yhdisteitä
BR9600534A (pt) Novos compostos
BR9509760A (pt) Composto
BR9600251A (pt) Composto
NO973459D0 (no) Vismut-forbindelser
EE9800172A (et) Ühendid
NO974170D0 (no) Polyazacykloalkan-forbindelser
FI970151A (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
BR9601295A (pt) Composto
DE69607714T2 (de) Zusammengesetzte Rutsche
BR9509740A (pt) Compostos 18-nor-vitamina d
BR9611576A (pt) Composto
BR9609639A (pt) Compostos pesticidas
ID18956A (id) Senyawa-senyawa herbisida
BR1100842A (pt) Compostos
ITMI950031A0 (it) Composti dibenzoalchilenici
BR9606742A (pt) Compostos pesticidas
BR9606744A (pt) Compostos pesticidas
SE9503561D0 (sv) New Compounds
SE9502559D0 (sv) Novel compounds
SE9404416D0 (sv) Novel compounds
DE69626884D1 (de) Schleusentor